QIAGEN N.V.: QIAGEN receives U.S. FDA emergency use authorization for rapid portable test that can analyze over 30 samples per hour for SARS-CoV-2 antigen

Approval gives U.S. healthcare professionals access to a new combination of scalability and speed QIAreach SARS-CoV-2 Antigen Test, developed in collaboration with Ellume, is easy to use and provi...